Junshi Biosciences Receives NMPA Approval of sNDA for
--5th approved indication by NMPA significantly expands eligible patient population...
Source: globenewswire.com
Stay updated with breaking news from Ir Team. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
--5th approved indication by NMPA significantly expands eligible patient population...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Investegate announcements from Junshi Biosciences, Junshi Biosciences and Coherus Receive Complete Response Letter from U.S. FDA for Toripalimab BLA
Investegate announcements from Etalon Group PLC, Etalon Group Publishes 2021 Annual Report
Investegate announcements from Etalon Group PLC, Etalon Group Reports 1Q 2022 Operating Results